Literature DB >> 2137655

Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype.

M A Bean1, E Mickelson, J Yanagida, S Ishioka, G E Brannen, J A Hansen.   

Abstract

Forty-seven patients with end-stage renal disease were entered into a donor-specific transfusion protocol consisting of three infusions of whole blood every two weeks prior to transplantation. Fourteen of the patients became sensitized following transfusion and were not transplanted. Thirty-one patients received a transplant from the DST donor and have an estimated two-year graft survival of 97%, three-year survival of 88%, and four-year survival of 69%. Cells of eleven of the 36 recipients tested in one-way MLC before and two weeks after completion of DST exhibited a significantly decreased antidonor MLC response. Deletion of CD8+ positive lymphocytes from suppressed MLCs resulted in restoration of antidonor MLC reactivity in four of six patients. An analysis of the family HLA profile in patients exhibiting a decreased donor-directed MLC response revealed a significant (P less than 0.02) association between decreased MLC reactivity following DST and the expression of noninherited maternal HLA antigens by cells of the transfusion donor. These alterations in cellular immune responses noted in some patients following DST are consistent with the appearance of specific antidonor T suppressor cells as a result of donor-specific transfusion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137655     DOI: 10.1097/00007890-199002000-00031

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Therapeutic potential for blockade of the CD40 ligand, gp39.

Authors:  J E Buhlmann; R J Noelle
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

Review 2.  HLA and pregnancy: the paradox of the fetal allograft.

Authors:  C Ober
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

3.  Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.

Authors:  Yoshinobu Akiyama; Stéphane M Caucheteux; Cécile Vernochet; Yoshiko Iwamoto; Katsunori Tanaka; Colette Kanellopoulos-Langevin; Gilles Benichou
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

4.  Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.

Authors:  C B Davies; J W Alexander; B R Cofer; M R First; T J Schroeder
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

5.  Do maternal cells trigger or perpetuate autoimmune diseases in children?

Authors:  Anne M Stevens
Journal:  Pediatr Rheumatol Online J       Date:  2007-05-16       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.